Why the US center for medicare and medicaid services should not extend reimbursement indications for carotid artery angioplasty/stenting

Angiology

Volumn 63, Issue 8, 2012, Pages 639-644

  Abbott, Anne L ^a   Adelman, Mark A ^b   Alexandrov, Andrei V ^c   Barnett, Henry J M ^d   Beard, Jonathan ^e   Bell, Peter ^f,g   Björck, Martin ^g   Blacker, David ^h   Buckley, Clifford J ^i,j,k   Cambria, Richard P ^l,m   Comerota, Anthony J ⁿ   Connolly, E Sander ^o   Davies, Alun H ^p   Eckstein, Hans Henning ^q,r   Faruqi, Rishad ^s,t,u   Fraedrich, Gustav ^v   Gloviczki, Peter ^w   Hankey, Graeme J ^x   Harbaugh, Robert E ^y,z   Heldenberg, Eitan ^aa   Kittner, Steven J ^ab   Kleinig, Timothy J ^ac,ad   Mikhailidis, Dimitri P ^ae   Moore, Wesley S ^af   Naylor, Ross ^ag   Nicolaides, Andrew ^ah   Paraskevas, Kosmas I ^e   Pelz, David M ^ai   Prichard, James W ^aj   Purdie, Grant ^ak   Ricco, Jean Baptiste ^al   Riles, Thomas ^am   Rothwell, Peter ^an   Sandercock, Peter ^ao   Sillesen, Henrik ^e   Spence, J David ^ap,aq   Spinelli, Francesco ^ar   Tan, Aaron ^ac   Thapar, Ankur ^as   Veith, Frank J ^t,am,at   Zhou, Wei ^au,av   more..

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d KLINIKUM NÜRNBERG   (Germany)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f NORTHERN GENERAL HOSPITAL   (United Kingdom)

^g UNIVERSITY OF LEICESTER   (United Kingdom)

^h UPPSALA UNIVERSITY   (Sweden)

ⁱ SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^j TEXAS A M COLLEGE OF MEDICINE   (United States)

^k SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁿ HARVARD MEDICAL SCHOOL   (United States)

^o TOLEDO HOSPITAL   (United States)

^p Toledo Hospital ^*  (United States)

^q IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^r TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^s TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^t STANFORD UNIVERSITY   (United States)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^w MAYO CLINIC   (United States)

^x UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^y Penn State Institute of the Neurosciences   (United States)

^z PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^aa TEL AVIV UNIVERSITY   (Israel)

^ab UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^ac Division of Neurology and Medicine   (Australia)

^ad UNIVERSITY OF ADELAIDE   (Australia)

^ae ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^af UNIVERSITY OF CALIFORNIA   (United States)

^ag LEICESTER ROYAL INFIRMARY   (United Kingdom)

^ah IMPERIAL COLLEGE LONDON   (United Kingdom)

^ai YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aj QUEEN ELIZABETH HOSPITAL   (Australia)

^ak UNIVERSITÉ DE POITIERS   (France)

^al NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^am UNIVERSITY OF OXFORD   (United Kingdom)

^an WESTERN GENERAL HOSPITAL   (United Kingdom)

^ao University of Copenhagen   (Denmark)

^ap ROBARTS RESEARCH INSTITUTE   (Canada)

^aq UNIVERSITY OF MESSINA   (Italy)

^ar CHARING CROSS HOSPITAL   (United Kingdom)

^as CASE WESTERN RESERVE UNIVERSITY   (United States)

^at Uniformed Services University of the Health Sciences   (United States)

^au Division of Vascular and Endovascular Surgery   (United States)

^av Health Care System   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAROTID ANGIOPLASTY; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; GOVERNMENT; HEALTH CARE COST; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; LETTER; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REIMBURSEMENT; SURGICAL RISK;

EID: 84870658681     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319711436076     Document Type: Letter

References (56)

1. Mayberg MR, Wilson SE, Yarsu F, et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA. 1991 ; 266 (23). 3289-3294
2. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998 ; 351 (9113). 1379-1387
3. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1991 ; 325 (7). 445-453
4. Hobson RW, Weiss DG, Fields WS, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med. 1993 ; 328 (4). 221-227
5. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995 ; 273 (118). 1421-1428
6. Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004 ; 363 (9420). 1491-1502
7. Halliday A, Harrison M. Hayter E, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): A multicentre randomised trial. Lancet. 2010 ; 376 (9746). 1074-1084
8. Rerkasem K, Rothwell PM. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev. 2011 ; (4). CD001081
9. Chambers BR, Donnan GA. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev. 2005 ; (4). CD001923
10. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: Results of a systematic review and analysis. Stroke. 2009 ; 40 (10). e573 - e583
11. Abbott AL Presented at the 37th Annual Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium). New York Hilton, New York City: ; 2010 :
12. Naylor AR, Gaines P, Rothwell P. Who benefits most from interventions for asymptomatic carotid stenosis: Patients or professionals?. Eur J Vasc Endovasc Surg. 2009 ; 37 (3). 625-632
13. Naylor AR. What is the current status of invasive treatment of extracranial carotid artery disease?. Stroke. 2011 ; 42 (7). 2080-2085
14. Spence JD, Coates V, Li H, et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol. 2010 ; 67 (2). 180-186
15. Rothwell PM, Coull AJ, Giles MF, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004 ; 363 (9425). 1925-1933
16. Broderick JP. The challenges of intracranial revascularization for stroke prevention. N Engl J Med. 2011 ; 365 (11). 1054-1055
17. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011 ; 365 (11). 993-1003
18. Unal B, Critchley JA, Fidan D, Capewell S. Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000. Am J Public Health. 2005 ; 95 (1). 103-108
19. Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2 011 ; 42 (2). 517-584
20. Furie KL, Kasner SE, Admas RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 ; 42 (1). 227-276
21. Goessens BM, Visseren FL, Kapelle LJ, Algra A, van der Graaf Y. Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: The SMART study. Stroke. 2007 ; 38 (5). 1470-1475
22. Markus HS, King A, Shipley M, et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol. 2010 ; 9 (7). 663-671
23. Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke. 2010 ; 41 (1). e11 - e17
24. Brott TG, Hobson RW, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 ; 363 (1). 11-23
25. Brooks WH, McClure RR, Jones MR, Coleman TL, Breathitt L. Carotid angioplasty and stenting versus carotid endarterectomy for treatment of asymptomatic carotid stenosis: a randomized trial in a community hospital. Neurosurgery. 2004 ; 54 (2). 318-324
26. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 ; 351 (15). 1493-1501
27. Brott TG, Halperin JL, Abbara S, et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/ CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Stroke. 2011 2011 ; 42 (8). e420-63
28. Sidawy AN, Zwolak RM, White RA, Siami FS, Schermerhorn ML, Sicard GA. Outcomes Committee for the Society for Vascular Surgery. Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS vascular registry. J Vasc Surg. 2009 ; 49 (1). 71-79
29. Rockman CB, Garg K, Jacobowitz GR, et al. Outcome of carotid artery interventions among female patients, 2004 to 2005. J Vasc Surg. 2011 ; 53 (6). 1457-1464
30. Giles KA, Hamdan AD, Pomposelli FB, Wyers MC, Schermerhorn ML. Stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria. J Vasc Surg. 2010 ; 52 (6). 1497-1504
31. Blackshear JL, Roubin GS, Hill MD, Leimgruber PP. Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation. 2011 ; 123 (22). 2571-2578
32. Naylor AR. Hearts and Minds. Eur J Vasc Endovasc Surg. 2012 ; 43: 1-3
33. Paraskevas KI, Moore WS, Veith FJ. Cost implications of more widespread carotid artery stenting consistent witht the American College of Cardiology/American Heart Association Guideline. J Vasc Surg. 2012 ; 55: 585-587
34. Hertzer NR. The nationwide inpatient sample may contain inaccurate data for carotid endarterectomy and carotid stenting. J Vasc Surg. 2012 ; 55: 263-266
35. Hankey GJ. Ischaemic stroke-prevention is better than cure. J R Coll Physicians Edinb. 2010 ; 40 (1). 56-63
36. Spence JD, Pelz D, Veith FJ. Asymptomatic Carotid Stenosis: identifying patients at high enough risk to warrant endarterectomy or stenting. Stroke. 2011 ;: 42
37. Naylor AR. Time to rethink management strategies in asymptomatic carotid artery disease. Nat Rev Cardiol. 2012 ; 9: 116-24
38. Bell P Presented at the 38th Annual Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium). New York Hilton, New York City: ; 2011 :
39. Redberg RF. Squandering Medicare's money. New York Times. :
40. Nallamothu BK, Lu M, Rogers MA, Gurm HS, Birkmeyer JD. Physician specialty and carotid stenting among elderly medicare beneficiaries in the United States. Arch Intern Med. 2011 ; 171 (20). 1804-1810
41. Berkowitz SA, Redberg RF. Dramatic increases in carotid stenting despite nonconclusive data. Arch Intern Med. 2011 ; 171 (20). 1794-1795
42. Paraskevas KI, Veith FJ, Riles TS, Moore WS. Is carotid artery stenting a fair alternative to carotid endarterectomy for symptomatic carotid artery stenosis?. Eur J Vasc Endovasc Surg. 2011 ; 41 (6). 717-719
43. Paraskevas KI, Veith FJ, Riles TS, Moore WS. Is carotid artery stenting a fair alternative to carotid endarterectomy for symptomatic carotid artery stenosis? A commentary on the AHA/ASA guidelines. J Vasc Surg. 2011 ; 54 (2). 541-543
44. Silver FL, Mackey A, Clark WM, et al. Safety of Stenting and Endarterectomy by Symptomatic Status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke. 2011 ; 42 (3). 675-680
45. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006 ; 355 (16). 1660-1671
46. Ederle J, Dobson J, Featherstone RL, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010 ; 375 (9719). 985-997
47. Mas JL, Trinquart L, Leys D, et al. Endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol. 2008 ; 7 (10). 885-892
48. Bonati LH, Dobson J, Algra A, et al. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet. 2010 ; 376 (9746). 1062-1073
49. Economopoulos KP, Sergentanis TN, Tsivgoulis G, Mariolis AD, Stefanadis C. Carotid artery stenting versus carotid endarterectomy: A comprehensive meta-analysis of short-term and long-term outcomes. Stroke. 2011 ; 42 (3). 687-692
50. Paraskevas KI, Mikhailidis DP, Moore WS, Veith FJ. Optimal contemporary management of symptomatic and asymptomatic carotid artery stenosis. Vascular. 2011 ; 19 (3). 117-120
51. an Inter-collegiate Committee of the RACP (ANZAN, CSANZ), RACS (ANZSVS) and RANZCR. Guidelines for patient selection and performance of CAS. Intern Med J. 2011 ; 41 (4). 344-347
52. Bonati LH, Fraedrich G.. Age modifies the relative risk of stenting versus endarterectomy for symptomatic carotid stenosis-A pooled analysis of EVA-3 S, SPACE and ICSS. Eur J Vasc Endovasc Surg. 2011 ; 41 (2). 153-158
53. Bonati LH, Jongen LM, Haller S, et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol. 2010 ; 9 (4). 353-362
54. Eckstein HH, Ringleb P, Allenberg JR, et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol. 2008 ; 7 (10). 893-902
55. Bonati LH, Ederle J, McCabe DJ, et al. Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Lancet Neurol. 2009 ; 8 (10). 908-917
56. Arquizan C, Trinquart L, Touboul PJ, et al. Restenosis is more frequent after carotid stenting than after endarterectomy: The EVA-3S study. Stroke. 2011 ; 42 (4). 1015-1020